Detalles de la búsqueda
1.
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Am Heart J
; 228: 109-115, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882569
2.
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.
Catheter Cardiovasc Interv
; 96(5): E508-E515, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237060
3.
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Catheter Cardiovasc Interv
; 96(2): E110-E118, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625262
4.
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet
; 388(10060): 2607-2617, 2016 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806902
5.
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
Lancet
; 383(9915): 413-23, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183564
6.
Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.
Am Heart J
; 169(1): 69-77, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497250
7.
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
Catheter Cardiovasc Interv
; 85(3): E76-82, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25339110
8.
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome.
Catheter Cardiovasc Interv
; 85(1): 74-81, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24585502
9.
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial.
Catheter Cardiovasc Interv
; 82(3): 396-405, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359390
10.
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents.
Catheter Cardiovasc Interv
; 80(4): 524-30, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22109857
11.
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.
JAMA Cardiol
; 4(7): 659-669, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31111862
12.
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
J Am Heart Assoc
; 7(3)2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29382666
13.
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Int J Cardiol
; 268: 11-17, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801763
14.
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
JACC Cardiovasc Interv
; 11(5): 448-459, 2018 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454724
15.
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
JACC Cardiovasc Interv
; 11(5): 462-469, 2018 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29519378
16.
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.
EuroIntervention
; 13(10): 1168-1176, 2017 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29151439
17.
Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Cardiol
; 2(3): 268-276, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28114618
18.
Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.
J Cardiol
; 69(4): 660-665, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27476343
19.
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study.
EuroIntervention
; 11(13): 1487-94, 2016 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26465376
20.
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial.
EuroIntervention
; 12(4): 431-40, 2016 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26342469